GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XTER:NP5) » Definitions » Price-to-Operating-Cash-Flow

Newron Pharmaceuticals SpA (XTER:NP5) Price-to-Operating-Cash-Flow : (As of Oct. 31, 2024)


View and export this data going back to . Start your Free Trial

What is Newron Pharmaceuticals SpA Price-to-Operating-Cash-Flow?

As of today (2024-10-31), Newron Pharmaceuticals SpA's share price is €8.89. Newron Pharmaceuticals SpA's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.73. Hence, Newron Pharmaceuticals SpA's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Newron Pharmaceuticals SpA's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Newron Pharmaceuticals SpA's highest Price-to-Operating-Cash-Flow Ratio was 20.80. The lowest was 10.15. And the median was 14.87.

XTER:NP5's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 26.97
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Newron Pharmaceuticals SpA's Cash Flow from Operations per share for the six months ended in Jun. 2024 was €-0.48. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.73.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 17.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 15.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 6.00% per year.

During the past 13 years, Newron Pharmaceuticals SpA's highest 3-Year average Operating Cash Flow per Share Growth Rate was 45.50% per year. The lowest was -16.20% per year. And the median was 7.50% per year.


Newron Pharmaceuticals SpA Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Newron Pharmaceuticals SpA's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newron Pharmaceuticals SpA Price-to-Operating-Cash-Flow Chart

Newron Pharmaceuticals SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Newron Pharmaceuticals SpA Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Newron Pharmaceuticals SpA's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Newron Pharmaceuticals SpA's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Newron Pharmaceuticals SpA's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Newron Pharmaceuticals SpA's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Newron Pharmaceuticals SpA's Price-to-Operating-Cash-Flow falls into.



Newron Pharmaceuticals SpA Price-to-Operating-Cash-Flow Calculation

Newron Pharmaceuticals SpA's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=8.89/-0.73
=

Newron Pharmaceuticals SpA's Share Price of today is €8.89.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Newron Pharmaceuticals SpA's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.73.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Newron Pharmaceuticals SpA Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Newron Pharmaceuticals SpA's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Newron Pharmaceuticals SpA Business Description

Traded in Other Exchanges
Address
Via Antonio Meucci 3, Bresso, Milan, ITA, 20091
Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.
Executives
Stefan Weber Board of Directors
Dr. Ulrich Köstlin Supervisory Board

Newron Pharmaceuticals SpA Headlines

No Headlines